Erythema gyratum repens. A case studied with immunofluorescence, immunoelectron microscopy and immunohistochemistry. 1994

F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
Service de Dermatologie, Hôpital Saint-Louis, Paris, France.

We report a patient with erythema gyratum repens (EGR), in whom a bronchial carcinoma was found. Direct immunofluorescence revealed granular deposits of immunoglobulins at the basement membrane zone (BMZ) in the skin, and in the lung tumour. Direct immunoelectron microscopy showed that the immune deposits were localized just beneath the lamina densa. Indirect immunofluorescence revealed circulating anti-BMZ antibodies. Immunohistochemical staining, using anti-transforming growth factor-beta, anti-epidermal growth factor receptor, anti-vimentin and anti-alpha-actin, was found to be more intense in the lesional skin and the lung tumour than in normal tissues. Possible mechanisms in the pathogenesis of EGR are discussed.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010257 Paraneoplastic Syndromes In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. Paraneoplastic Syndrome,Syndrome, Paraneoplastic,Syndromes, Paraneoplastic
D002283 Carcinoma, Bronchogenic Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA. Carcinoma, Bronchial,Bronchial Carcinoma,Bronchial Carcinomas,Bronchogenic Carcinoma,Bronchogenic Carcinomas,Carcinomas, Bronchial,Carcinomas, Bronchogenic
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D004890 Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Erythemas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
September 1993, Journal of the American Academy of Dermatology,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
January 1964, Dermatologica,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
February 1995, JAMA,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
August 2020, JAMA dermatology,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
December 1979, Ugeskrift for laeger,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
May 2011, Journal of the American Academy of Dermatology,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
February 1985, Archives of dermatology,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
November 1961, Dermatologica,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
January 1966, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
F Caux, and C Lebbe, and E Thomine, and B Benyahia, and B Flageul, and P Joly, and M Rybojad, and P Morel
May 1959, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!